News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
674,495 Results
Type
Article (38548)
Company Profile (191)
Press Release (635756)
Section
Business (202842)
Career Advice (1957)
Deals (35333)
Drug Delivery (74)
Drug Development (80448)
Employer Resources (167)
FDA (15929)
Job Trends (14751)
News (342686)
Policy (32377)
Tag
Academia (2524)
Africa (708)
Allergies (37)
Alliances (48858)
Alzheimer's disease (1093)
Antibody-drug conjugate (ADC) (43)
Approvals (15872)
Arizona (159)
Artificial intelligence (48)
Asia (36566)
Australia (5944)
Bankruptcy (350)
Best Places to Work (11171)
Biosimilars (55)
C2C Services and Suppliers (78801)
California (820)
Canada (641)
Cancer (176)
Career advice (1635)
CAR-T (32)
Cell therapy (65)
China (48)
Clinical research (62577)
Collaboration (56)
Colorado (33)
Compensation (30)
COVID-19 (2452)
Cystic fibrosis (69)
Diabetes (32)
Diagnostics (5888)
Diversity, equity & inclusion (44)
Drug pricing (47)
Earnings (82757)
Employer resources (141)
Europe (78083)
Events (106897)
FDA (15973)
Florida (106)
Funding (37)
Gene therapy (52)
GLP-1 (465)
Government (4272)
Healthcare (18525)
Hotbed/Location (481031)
Idaho (55)
Illinois (194)
Indiana (105)
Infectious disease (2465)
Inflammatory bowel disease (83)
Interviews (305)
IPO (16114)
Job creations (3616)
Job search strategy (1410)
Kansas (90)
Layoffs (372)
Legal (7814)
Liver cancer (51)
Lung cancer (37)
Maine (47)
Management (53)
Manufacturing (45)
Maryland (251)
Massachusetts (450)
Medical device (12944)
Medtech (12947)
Mergers & acquisitions (18920)
Metabolic disorders (154)
Neuroscience (1170)
New Jersey (62)
New York (83)
NextGen Class of 2024 (6445)
Non-profit (4441)
North Carolina (158)
Obesity (101)
Opinion (160)
Parkinson's disease (29)
Patents (33)
Peanut (33)
Pennsylvania (55)
People (55518)
Phase I (19398)
Phase II (27566)
Phase III (20607)
Policy (33)
Postmarket research (2544)
Preclinical (8270)
Rare diseases (89)
Real estate (5877)
Recruiting (63)
Regulatory (21010)
Reports (32)
Research institute (2297)
Resumes & cover letters (343)
South America (1085)
Startups (3547)
Texas (87)
United States (3002)
Vaccines (408)
Washington State (113)
Weight loss (96)
Date
Today (13)
Last 7 days (496)
Last 30 days (1789)
Last 365 days (38209)
2024 (21594)
2023 (40074)
2022 (51173)
2021 (55713)
2020 (54087)
2019 (46542)
2018 (35020)
2017 (32111)
2016 (31480)
2015 (37554)
2014 (31318)
2013 (26346)
2012 (28570)
2011 (29263)
2010 (27328)
674,495 Results for "discgenics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
DiscGenics to Present at Canaccord Genuity 2024 Musculoskeletal Conference
DiscGenics, Inc. today announced that Flagg Flanagan, Chief Executive Officer and Chairman of DiscGenics will present at Canaccord Genuity’s 2024 Musculoskeletal Conference.
February 8, 2024
·
2 min read
BioMidwest
DiscGenics to Present at Biotech Showcase 2024
DiscGenics, Inc. announced that Flagg Flanagan, Chief Executive Officer and Chairman of DiscGenics is presenting at Biotech Showcase 2024.
January 4, 2024
·
2 min read
BioMidwest
DiscGenics CEO to Present at Upcoming Industry Conferences
DiscGenics, Inc. announced that Flagg Flanagan, Chief Executive Officer and Chairman of DiscGenics will present at the following conferences.
September 26, 2023
·
2 min read
DiscGenics to Present at Canaccord Genuity’s 2023 Musculoskeletal Conference
DiscGenics, Inc. today announced that it will present at Canaccord Genuity’s 18th Annual Musculoskeletal Conference taking place in Las Vegas, NV on Tuesday, March 7, 2023.
February 28, 2023
·
1 min read
BioMidwest
DiscGenics to Present at 41st Annual J.P. Morgan Healthcare Conference
DiscGenics, Inc. announced that it will be participating in the 41st Annual J.P. Morgan Healthcare Conference taking place in San Francisco, CA on January 9 – 12, 2023.
January 4, 2023
·
1 min read
DiscGenics to Present at 2022 Cell & Gene Meeting on the Mesa
DiscGenics, Inc. today announced that Flagg Flanagan, Chief Executive Officer and Chairman will present virtually at the annual Cell & Gene Meeting on the Mesa to be held October 11-13 in Carlsbad, California and livestreamed globally.
October 5, 2022
·
2 min read
DiscGenics Announces FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted to IDCT for Degenerative Disc Disease
DiscGenics, Inc. today announced the U.S. Food and Drug Administration (FDA) granted Regenerative Medicine Advanced Therapy (RMAT) designation to Injectable Disc Cell Therapy (IDCT or rebonuputemcel), an injectable, allogeneic discogenic progenitor cell therapy for the treatment of symptomatic lumbar degenerative disc disease (DDD).
January 26, 2023
·
3 min read
DiscGenics Announces Positive Two-Year Clinical Data from Study of Discogenic Progenitor Cell Therapy for Degenerative Disc Disease
DiscGenics, Inc. today announced positive two-year clinical data from its first-in-human clinical study of IDCT (rebonuputemcel), an allogeneic discogenic progenitor cell therapy for lumbar degenerative disc disease (DDD).
January 23, 2023
·
8 min read
Drug Development
Our Mission at Voyager Therapeutics: Define the Future of Neurogenetic Medicines
We are in an unprecedented time in neurotherapeutics. Medicines that address the causative disease biology underlying central nervous system
May 8, 2024
·
3 min read
·
Voyager Therapeutics, Inc.
Press Releases
Verrica Pharmaceuticals Announces Litigation Settlement with Dormer Laboratories, Inc.
Verrica Pharmaceuticals Inc. today announced the settlement of litigation with Dormer Laboratories, Inc. (“Dormer Labs”).
July 1, 2024
·
5 min read
1 of 67,450
Next